Top compounds associated with response to EIF2S3


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112 GDSC1000 pan-cancer AAC 0.068 0.03
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.17 0.03
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.073 0.03
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.068 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.03
mRNA AUY922 GDSC1000 pan-cancer AAC 0.079 0.03
mRNA BX-795 GDSC1000 pan-cancer AAC 0.078 0.03
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.076 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA semagacestat CTRPv2 pan-cancer AAC -0.084 0.03
Download CSV